# US 2015/0301037 A1 · Use of diazolidinyl urea for anti-clumping of biological samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0301037 A1
- Document ID: US20150301037A1
- Status: Published application
- Kind: A1
- Application number: 14/695,455
- Filed: 2015-04-24
- Published: 2015-10-22
- Earliest claimed: 2010-09-23
- Applicants: Biocept, Inc.
- Inventors: Pavel TSINBERG; Stephen D. MIKOLAJCZYK
- Web page: https://patentgrep.com/patent/US20150301037A1

## CPC

- G01N 33/54393: {Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding}
- A61B 5/1405: {Devices for taking blood samples (devices for taking samples of other body liquids A61B10/0045)}
- A61B 5/150343: {Collection vessels for collecting blood samples from the skin surface, e.g. test tubes, cuvettes (sampling from within body cavities A61B5/150015, A61B5/150045)}
- A61B 5/150755: {Blood sample preparation for further analysis, e.g. by separating blood components or by mixing}
- A61B 5/154: {Devices} using pre-evacuated means
- A61B 10/02: Instruments for taking cell samples or for biopsy {(A61B10/0038 and A61B10/0045 take precedence; needle locating or guiding means A61B17/3403; samplers for enzymology or microbiology C12M1/26; sampling or preparing biological specimens G01N33/48)}
- Y10T 436/17: Nitrogen containing
- Y10T 436/171538: Urea or blood urea nitrogen
- Y10T 436/173845: Amine and quaternary ammonium
- Y10T 436/174614: Tertiary amine
- Y10T 436/25: including sample preparation
- Y10T 436/2525: Stabilizing or preserving
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present invention provides methods for preventing clumping of cells in microfluidic devices by addition of diazolidinyl urea (DU). DU can be added to samples at the time of collection or can be added to samples post-collection. DU can also be pre-added to sample collection devices.

## Claims

### Claim at position 1

-7. (canceled)

### Claim 8

A container for collecting biological samples comprising an effective amount of diazolidinyl urea sufficient for inhibiting cellular aggregation in combination with a non-chelating agent based anti-coagulating agent, wherein the effective amount of diazolidinyl urea is an amount that provides substantial anti-cellular-aggregation activity but insubstantial activity for preserving cells in a biological sample upon mixing with the biological sample

### Claim 9 (depends on 8)

The container of claim 8, wherein the volume of the container is from about 0.5 mL to about 50 mL, and wherein the diazolidinyl urea is at a concentration of about 4% to about 60% in the absence of the biological sample.

### Claim 10 (depends on 8)

The container of claim 8, wherein the non-chelating agent based anti-coagulating agent is acid citrate dextrose.

### Claim 11 (depends on 8)

The container of claim 8, further comprising a biological sample.

### Claim 12 (depends on 8)

The container of claim 8, wherein the diazolidinyl urea is in a solid or liquid form.

### Claim 13

A container for collecting biological samples comprising an effective amount of diazolidinyl urea sufficient for inhibiting cellular aggregation, wherein the effective amount of diazolidinyl urea is an amount that provides substantial anti-cellular-aggregation activity but insubstantial activity for preserving cells in a biological sample upon mixing with the biological sample.

### Claim 14 (depends on 13)

The container of claim 13, further comprising a non-chelating agent based anti-coagulating agent.

### Claim 15 (depends on 13)

The container of claim 13, further comprising an effective amount of acid citrate dextrose.

### Claim 16 (depends on 13)

The container of claim 13, further comprising a biological sample.

### Claim 17 (depends on 13)

The container of claim 13, wherein the diazolidinyl urea is in a solid or liquid form.

### Claim 18

A container for collecting biological samples having a size from about 0.5 mL to about 50 mL and diazolidinyl urea in an amount from about 0.02 grams to about 30 grams, wherein the amount of diazolidinyl urea is an amount that provides substantial anti-cellular-aggregation activity but insubstantial activity for preserving cells in a biological sample upon mixing with the biological sample.

### Claim 19 (depends on 8)

The container of claim 8, further comprising an instruction for using the container to collect a biological sample.

### Claim 20 (depends on 18)

The container of claim 18, wherein the diazolidinyl urea is in a solid or liquid form.

### Claim 21 (depends on 19)

The container of claim 19 wherein the instruction comprises using diazolidinyl urea in the amount of about 0.01% to about 3% upon mixing with the biological sample.

### Claim 22 (depends on 19)

The container of claim 19 wherein the instruction comprises using diazolidinyl urea in the amount of about 0.1% to about 2.5% upon mixing with the biological sample.

### Claim 23 (depends on 19)

The container of claim 19 wherein the instruction comprises using diazolidinyl urea in the amount of about 0.2% to about 2% upon mixing with the biological sample.
